Cohort Study: SGLT2 Inhibitors Associated with Reduced Risk of Heart Failure
30 Aug, 2019 | 08:24h | UTCCommentaries: SGLT2 inhibitors cut heart failure risk for T2D patients – Cardiovascular Business (free) AND Newer diabetes drug drops heart failure risk by 34 percent, study says – UPI (free)
Related observational studies: SGLT2 agents may reduce cardiovascular risk in diabetics (link to abstract and commentaries)